We are very pleased to share that the Prix Galien USA 2018 awarding ceremony was held on October 25th, at the New York City Museum of Natural History . Congratulations to all the winners and the finalists, as well!
Please press here for the relevant press release.
And the winners are…..
Best Pharmaceutical Product:
IDHIFA™, Celgene Corporation & Agios Pharmaceuticals, Inc.
The first oral targeted therapy for adult patients with relapsed/refractory acute myeloid leukemia and an IDH2 mutation.
Best Biotechnology Product:
Yescarta™ Kite, a Gilead Sciences company
FDA approval of Yescarta is a landmark for patients with relapsed or refractory large B-cell lymphoma.
Kymriah™ Novartis Pharmaceuticals Corporation
CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia.
Best Medical Technology:
WATCHMAN™ Boston Scientific
Left Atrial Appendage Closure Device – The one-time procedure that may provide a lifetime of stroke risk reduction in NVAF patients who need an alternative.
